Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Infertility Coverage topic
No spam. Unsubscribe anytime.
Fertility coverage bill draws clash between patient advocates and insurers over cost and fairness
Summary
HB 4155 would mandate private insurers cover some fertility services (IUI, IVF, preservation); patient advocates and clinicians urged passage for equity and access, while insurers and industry groups warned of significant premium impacts, implementation complexity, and concerns about excluding public plans.
Representative Lucetta Elmer presented House Bill 4155 to require insurance coverage for family-building services including intrauterine insemination (IUI), in vitro fertilization (IVF) and medically indicated fertility preservation. The dash-4 amendment discussed on Feb. 10 would remove the Public Employees' Benefit Board (PEB) and the Oregon Educators Benefit Board (OEB) from the mandate to improve the bill's prospects.
Patients, reproductive medicine clinicians and advocates described high out-of-pocket costs for IVF and fertility treatment, health-equity concerns, and the emotional burden for those unable to access care. Several witnesses said other states have enacted similar mandates and no state has walked back coverage once adopted; experts testified that coverage can reduce aggressive treatment cycles and improve outcomes.
Insurers, brokers and benefit consultants — including Providence, Regence, PacificSource, Moda, and NABIP — warned the committee the mandate could materially increase premiums (witnesses cited estimates ranging from small to several dollars per member per month up to higher actuarial estimates) and create administrative complexity (coordination of coverage for gestational carriers, storage liabilities, national guideline delegation and potential federal defrayal rules for exchange plans). Some insurers urged a deliberative study and collaborative design work rather than advancing the current bill.
Committee members asked about cost estimates, exclusions, and whether the bill applies only to medically indicated infertility; staff clarified the introduced bill would be limited to medically necessary infertility diagnoses. The committee closed the hearing with significant stakeholder differences remaining.
